Possible liver damage induced by chemicals or drugs must be detected e
arly during drug development or industrial exposure, although damage i
s still difficult to predict, especially when immunotoxicity is involv
ed. Liver toxicity may result from cytolysis, steatosis, cholestasis,
phospholipidosis, or vascular lesions, most the outcome of a disadvant
ageous balance between chemicals or metabolites vs protective mechanis
ms, resulting from chemical dosage, genetic factors, or the immunoalle
rgic status of the patient. Drug metabolism, lipid peroxidation, and t
hiol oxidation are frequently involved in liver toxicities. Classical
guidelines in toxicology propose many methods for liver toxicity asses
sment: histology; chemical changes in hepatic tissue (lipids, glutathi
one, enzymes); physiological changes in biosynthesis (proteins, glycop
roteins); excretion function (fructose); drug metabolism; and concentr
ations of related enzymes (alanine aminotransferase, aspartate aminotr
ansferase, alkaline phosphatase, and gamma-glutamyltransferase) in blo
od. In vitro studies in human or animal hepatocytes or tumor-derived c
ell lines are useful in detecting hepatocellular lesions by cell viabi
lity, glutathione concentration, amount of lactate dehydrogenase relea
sed, cellular ATP, morphology (blebs), and drug metabolism.